Hanseok Ko

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Synucleins 84%
3. Dopaminergic Neurons 33%
4. Glucosylceramidase 32%
5. Ubiquitination 27%
6. Ubiquitin-Protein Ligases 20%
7. Amino Acyl-tRNA Synthetases 18%
8. Phosphotransferases 18%
9. Mutation 17%
10. Brain 15%
11. Ubiquitin 14%
12. Parkinsonian Disorders 14%
13. Proteins 13%
14. Synucleinopathies 13%
15. PTEN-induced putative kinase 13%
16. Gaucher Disease 12%
17. Cell Death 12%
18. alpha-Synuclein 12%
19. Neurodegenerative Diseases 11%
20. Leucine 11%
21. Solubility 10%
22. Poly Adenosine Diphosphate Ribose 10%
23. Protein Disulfide-Isomerases 10%
24. Astrocytes 9%
25. Mitophagy 9%
26. Mesencephalon 9%
27. Microglia 9%
28. Protein-Tyrosine Kinases 9%
29. Transgenic Mice 9%
30. Pathology 9%
31. Tyrosine 8%
32. Neurons 8%
33. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 8%
34. Autophagy 7%
35. Phosphorylation 7%
36. Parthanatos 7%
37. 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 7%
38. Proteasome Endopeptidase Complex 7%
39. Substantia Nigra 7%
40. Alzheimer Disease 7%
41. human PSMC5 protein 7%
42. Amyloid 7%
43. 4-phenyl-1,2,3,6-tetrahydropyridine 7%
44. Dopamine 7%
45. Organoids 7%
46. 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 6%
47. Proto-Oncogene Proteins c-abl 6%
48. Glucagon-Like Peptide-1 Receptor 6%
49. Poly (ADP-Ribose) Polymerase-1 6%
50. Animal Models 6%